Oncology
Conference Coverage
Risk of atrial fibrillation 900% higher with cancer
MELBOURNE –
News
Mortality caused by chronic liver disease in setting of diabetes continues to rise
The findings underscore the need to better address nonalcoholic fatty liver disease and end-stage liver disease among individuals with diabetes....
News
Cancer deaths cost over $94 billion in lost earnings in 2015
“A substantial proportion of the mortality burden is potentially avoidable” with improved prevention and access to care.
Clinical Review
2019 Update on abnormal uterine bleeding
These experts discuss the factors that incur increased risk for malignant endometrial polyps, the relationship between chronic...
FDA/CDC
FDA approves pembrolizumab for advanced SCLC
The approval was based on an overall response rate of 19% in two nonrandomized trials.
Conference Coverage
EULAR issues guidelines on managing rheumatic complications of cancer immunotherapies
The new guidelines are tailored for rheumatologists, and address diagnosis and treatment.
FDA/CDC
FDA approves trastuzumab-anns for HER2-positive breast, gastric cancer
This is the fifth FDA approval of a trastuzumab biosimilar.
Conference Coverage
Pregnancy deemed safe in BRCA-mutated breast cancer survivors
Pregnancy did not affect disease-free or overall survival, and complications were similar to the general population.
FDA/CDC
The costs of surviving cancer
Annual out-of-pocket spending is 60% higher for survivors, the CDC reported.
Conference Coverage
Nephrectomy may benefit select renal cancer patients based on risk factors
CHICAGO – CARMENA update confirms cytoreductive nephrectomy should not be standard of care for most cases of metastatic renal cell carcinoma.